MedPath

上海创诺制药有限公司

Ownership
-
Established
2005-04-22
Employees
-
Market Cap
-
Website
http://www.acebright.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

25

NMPA:25

Drug Approvals

Bendamustine Hydrochloride for Injection

Product Name
注射用盐酸苯达莫司汀
Approval Number
国药准字H20244529
Approval Date
Jul 30, 2024
NMPA

Oxaliplatin Injection

Product Name
奥沙利铂注射液
Approval Number
国药准字H20244539
Approval Date
Jul 30, 2024
NMPA

多西他赛

Approval Number
国药准字H20103540
Approval Date
Jul 4, 2024
NMPA

Erlotinib Hydrochloride Tablets

Product Name
盐酸厄洛替尼片
Approval Number
国药准字H20204030
Approval Date
Jun 12, 2024
NMPA

Erlotinib Hydrochloride Tablets

Product Name
盐酸厄洛替尼片
Approval Number
国药准字H20193262
Approval Date
Jun 12, 2024
NMPA

Paclitaxel Injection

Product Name
紫杉醇注射液
Approval Number
国药准字H20103297
Approval Date
May 30, 2024
NMPA

Paclitaxel

Product Name
紫杉醇
Approval Number
国药准字H20103249
Approval Date
May 30, 2024
NMPA

Regorafenib Tablets

Product Name
瑞戈非尼片
Approval Number
国药准字H20243057
Approval Date
Jan 16, 2024
NMPA

Temozolomide Capsules

Product Name
替莫唑胺胶囊
Approval Number
国药准字H20234716
Approval Date
Dec 29, 2023
NMPA

Sorafenib Tosylate Tablets

Product Name
甲苯磺酸索拉非尼片
Approval Number
国药准字H20234644
Approval Date
Dec 13, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.